Sylvant 400mg: Affected lot is labelled with the incorrect expiry date found

ShaziaMedicine

Summary

Product

Sylvant

Issue

Health products – Product quality

What to do

Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.

Distribution

National

Ontario

Affected products

Filter items

Showing 1 to 1 of 1 entries

Show 102550100 entries

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot number

Sylvant 400mgSylvant 400mgDIN 02435136Powder For SolutionSiltuximab 400mg/FioleNDI46015.C

Issue

Affected lot is labelled with the incorrect expiry date found on the vial and carton.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers

Details

Original published date: 2025-05-02

Alert / recall type

Health product recall

Category

Health products – Drugs

Companies

Recordati Rare Diseases Canada Inc. 3080 Yonge Street Suite 6060, Toronto, ON, M4N 3N1

Published by

Health Canada

Audience

General public

Healthcare

Industry

Distribution

National

Ontario

Recall class

Type III

Identification number

RA-77381